Impact of IDO activation and alterations in the kynurenine pathway on hyperserotonemia, NAD production, and AhR activation in autism spectrum disorder.
Hyperserotonemia is the most replicated biochemical anomaly associated with autism spectrum disorder (ASD) and has been reported in 35-46% of individuals with ASD. Serotonin is synthesised from the essential amino acid...
Read More